INDELs acquired upstream of the TAL1 oncogene introduce de novo binding motifs for the TF MYB, which creates a SE and drives TAL1 overexpression in primary patient T-cell acute lymphoblastic leukemia (T-ALL) (Mansour et al., 2014). The gene discussed is TAL1; the disease is acute lymphoblastic leukemia.